Filing Details
- Accession Number:
- 0001493152-24-014512
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-15 06:04:01
- Reporting Period:
- 2024-04-11
- Accepted Time:
- 2024-04-15 06:04:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1642380 | Oncocyte Corp | OCX | In Vitro & In Vivo Diagnostic Substances (2835) | 271041563 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1956391 | Josh Riggs | C/O Oncocyte Corporation 15 Cushing Irvine CA 92618 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2024-04-11 | 3,390 | $2.95 | 3,505 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private offering.
Billionaire Hedge Funds
